An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

August 19, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

March 1, 2026

Conditions
Leukemia, Myeloid, Acute
Interventions
DRUG

CC-486

Specified dose on specified days

OTHER

Placebo

Specified dose on specified days

Trial Locations (34)

100044

Local Institution - 0013, Beijing

100191

Local Institution - 0027, Beijing

110001

Local Institution - 0005, Shenyang

110022

Local Institution - 0020, Shenyang

130021

Local Institution - 0017, Changchun

150086

Local Institution - 0032, Harbin

200025

Local Institution - 0006, Shanghai

210029

Local Institution - 0029, Nanjing

215006

Local Institution - 0021, Suzhou

221000

Local Institution - 0022, Xuzhou

230001

Local Institution - 0031, Hefei

250012

Local Institution - 0011, Jinan

300020

Local Institution - 0001, Tianjin

300052

Local Institution - 0023, Tianjin

310009

Local Institution - 0014, Hangzhou

325015

Local Institution - 0007, Wenzhou

330006

Local Institution - 0018, Nanchang

341000

Local Institution - 0035, Ganzhou

363000

Local Institution - 0034, Zhangzhou

400000

Local Institution - 0028, Chongqing

410008

Local Institution - 0019, Changsha

410013

Local Institution - 0015, Changsha

450008

Local Institution - 0004, Zhengzhou

510060

Local Institution - 0012, Guangzhou

510080

Local Institution - 0003, Guangzhou

Local Institution - 0008, Guangzhou

518055

Local Institution - 0010, Shenzhen

610041

Local Institution - 0016, Chengdu

650032

Local Institution - 0024, Kunming

710100

Local Institution - 0030, Xi'an

730030

Local Institution - 0026, Lanzhou

830011

Local Institution - 0009, Ürümqi

050000

Local Institution - 0002, Shijiazhuang

030013

Local Institution - 0033, Taiyuan

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY